Basigin is expressed in many tissues during development, includ-Basigin was identified as a product of human malignant ing lung. It is also found on tumor cells and in wounds where cells (6, 7) able to upregulate expression of interstitial collait is thought to stimulate adjacent fibroblasts to produce matrix genase by fibroblasts. Subsequently, it was found to induce metalloproteinases. To investigate whether basigin might be several matrix metalloproteinases (MMPs) (8-10). Reexpressed in fibro-inflammatory lung processes, we generated cently, murine basigin was shown to upregulate MMP exbleomycin-induced lung injury in mice. At 14 d after intratrapression by fibroblasts (11). Because MMPs have been imcheal bleomycin, we found basigin prominently in areas of fibroplicated in diffuse interstitial lung diseases (12-15) and sis, alveolar macrophages, and bronchiolar epithelium, whereas bleomycin-induced lung fibrosis (16-18), we hypothesized it was only weakly present in bronchiolar epithelium in untreated mice. Western blots of radioimmunoprecipitation assay that basigin may be involved in fibro-inflammatory lung RIPA-insoluble fractions of bleomycin-treated lungs showed inprocesses. To investigate this possibility, we generated bleocreased basigin compared with RIPA-insoluble fractions of lung mycin-induced lung injury in mice and assessed the lungs from untreated mice. By quantitative reverse transcriptase-polyfor basigin expression. merase chain reaction, lung basigin mRNA was significantly increased 14 d after bleomycin, and by in situ hybridization, basi-Materials and Methods gin mRNA was prominent in bronchiolar epithelium. Western blots of bronchoalveolar lavage fluid (BALF) showed various
neurothelin, and 5A11 in the chicken; gp42 in the mouse; and OX-47 and CE9 in the rat) is a member of the immunoglobulin superfamily of transmembrane proteins (1) . It is Antibodies to Murine Basigin a highly glycosylated protein of 43-66 kD with a protein core of ‫ق‬ 27 kD. The glycosylation varies considerably A polyclonal antibody to the entire extracellular (EC) domain of murine basigin was raised in rabbits as previously described (19) . among different tissues, suggesting diverse functions (2) . Briefly, to construct an expression vector of the EC, a cDNA frag-Basigin is expressed in many tissues during development, ment corresponding to the EC domain of mouse basigin, nt. 74including lung (3), but it is essentially absent in normal 637 (1) was inserted into the BamHI/XhoI sites of pGEX-5X-1 adult lung tissue. There is an undefined requirement for (Pharmacia, NJ), which was then used to transform bacteria. The basigin during development (most basigin-deficient emresultant glutathione-S-transferase (GST)-basigin EC fusion probryos do not survive to birth) (4) . Homology between hutein was used to immunize rabbits. To obtain basigin-specific polyman and murine basigin is 96% and 70% for the transmemclonal antibodies, the immune rabbit serum was passed sequenbrane and intracellular domains, respectively, and 51% for tially over a GST-affinity column and a basigin EC affinity column. the extracellular domains (5) . This antibody recognized basigin by Western blotting with the GST-basigin protein but did not develop any signal in extracts of tissues from basigin-deficient mice. This antibody was used for immunohistochemistry. For studies of basigin in bronchoalveolar lavage ( Received in original form May 8, 2002 and in revised form October 28, fluid (BALF) and in RIPA-soluble and RIPA-insoluble extracts 2002) of tissues, the monoclonal antibody MRC OX-47 (Serotec, Oxford,
Tissue Processing Western Blotting
Mouse lungs and testes were weighed and homogenized in RIPA Immediately after the animals were killed, the thorax was opened, and the lungs were perfused with saline through the right ventricle buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 nM Tris-HCl, pH 8.0) at 0.25 mg wet to remove blood. The lungs were inflated with 10% buffered formalin at a constant pressure of 20 cm H 2 O via the trachea for 20 min, wt/l (22) . The lysates were spun for 15 min at 4ЊC in a microcentrifuge, and the soluble fractions were removed. RIPA-insoluble excised, immersion fixed with 10% buffered formalin for 24 h, dehydrated, embedded in paraffin, and cut into 3-m sections. The pellets (ECM-enriched fractions) were weighed and washed once in RIPA buffer and boiled for 10 min in SDS-reducing sample testes were excised and processed in the same way.
buffer at 1 mg wet wt/l. BALF was boiled for 3 min in SDSreducing sample buffer. Samples were electrophoresed in a 10% SDS-polyacrylamide gel with pre-stained molecular weight mark-Immunohistochemistry ers (Bio-Rad, Hercules, CA). Proteins were transferred to poly-To localize basigin in the lung, immunohistochemistry was pervinylidene difluoride membranes (Millipore, Bedford, MA) with formed on paraffin-embedded tissue using a CSA kit (DAKO a semi-dry transfer cell (AE-6677; ATTO, Tokyo, Japan). Nonspe-Japan, Kyoto, Japan) according to the manufacturer's protocol.
cific binding sites were blocked with Tris-buffered saline containing Briefly, after deparaffinization and rehydration in graded ethanol, 0.1% Tween 20 and 5% nonfat dried milk for 1 h at room temperasections were washed with phosphate-buffered saline (PBS). Enture. Membranes were incubated with the monoclonal antibody dogenous peroxidase was blocked by incubation with 0.3% hydro-OX-47 overnight at 4ЊC. After three washes with Tris-buffered gen peroxide at room temperature for 15 min. The sections were saline-containing 0.1% Tween 20, the membranes were incubated incubated with the rabbit anti-basigin EC antibody in PBS at in horseradish peroxidase-conjugated anti-mouse immunoglobulin 1:1,000 for 15 min at room temperature. After being washed with at 1:10,000 dilution (DAKO). Sites of antibody binding were visual-PBS, the sections were incubated with goat anti-rabbit immunoized using the ECL Plus Western blotting detection system (Amerglobulin G-conjugated immunoperoxidase. Peroxidase activity was sham, Aylesbury, UK). visualized by incubation with diaminobenzidine tetrahydrochloride. The tissue sections were counterstained with methyl green and mounted. Sections that were not exposed to the primary anti-
Deglycosylation of Basigin
body were used as negative controls.
To determine whether the increased basigin in BALF after bleomycin was glycosylated, unconcentrated BALF obtained 7 d after intratracheal bleomycin was denatured by boiling for 3 min in Quantitative Reverse Transcriptase-Polymerase 0.5% SDS and 0.1 M ␤-mercaptoethanol followed by incubation
Chain Reaction
with or without 250 U/ml of N-glycanase (Calbiochem, San Diego, Total RNA was extracted from whole lungs by ToTally (Ambion, CA) at 37ЊC for 24 h. The reaction mixture was then subjected to Austin, TX) immediately after animals were killed (18). Reverse Western blot analysis as described above. transcription was carried out, and 5Ј exonuclease-based fluorogenic polymerase chain reaction (PCR) was performed using an ABI PRISM 7700 Sequence Detector (PE Applied Biosystems, Foster
Statistical Analysis
City, CA) as previously described (18). Oligonucleotide primers for basigin were derived from exon 5 of the murine basigin gene se-All data are expressed as means Ϯ SEM. Statistical differences quence (GenBank accession number D00611). The primers and among groups were determined using a one-factor analysis of probe, designed to meet the specific criteria for using Primer Express variance. Significance was defined at P Ͻ 0.05. software (PE Applied Biosystems), were as follows: sense-primer: 5Ј-GGGAAACCATCTCACTGCGT-3Ј; antisense-primer: 5Ј-TAG
Results
ATAAAGATGATGGTAACCAACACCA-3Ј; probe: 5Ј-FAM-CCTTCCTAGGCATCGTGGCTGAGGT-TAMRA-3Ј.
Lung Basigin Is Increased and Associated with Fibrotic
The predicted size of the amplified product was 102 bp, and Areas After Intratracheal Bleomycin the specific amplification was confirmed by ethidium bromide stain-Using polyclonal anti-basigin EC antibody, we found that ing on an agarose gel. Primers and a labeled probe for glyceraldebasigin was present only weakly in untreated lung and was hyde-3-phosphatase dehydrogenase (GAPDH) (TaqMan GAPDH control reagents), for an endogenous control, were purchased from confined to bronchiolar epithelial cells ( Figure 1A ). In con-PE Applied Biosystems. A mock PCR (without cDNA) was used trast, at 14 d after bleomycin, this antibody revealed basigin to exclude contamination. The relative amount of basigin mRNA in fibrotic areas, associated macrophages, and bronchiolar in the samples was normalized by GAPDH mRNA. epithelium ( Figure 1B ). To determine whether the basigin detected by the EC antibody in fibrotic areas reflected fulllength basigin, we attempted immunostaining with antibody In Situ Hybridization raised to the intracellular domain of basigin, but this anti-A fragment of cDNA encoding mouse basigin (nucleotides 1-891) body stained tissues only weakly-even tissues such as nor- ization, shown below, indicated that basigin mRNA is reused for in situ hybridization was published previously (21). Sense stricted to airway epithelial cells and is not present in areas controls were included with each hybridization and were handled identically to the corresponding antisense samples.
of fibrosis. Accordingly, the basigin seen in fibrotic areas after bleomycin seems to be basigin that has become associ-creased compared with controls and with lung basigin mRNA 7 d after intratracheal bleomycin instillation (P Ͻ ated with extracellular matrix after release from its cellular source.
0.05). The basigin mRNA level was back to baseline at 21 d. To confirm the apparent association of basigin with lung Lung Basigin mRNA Is Expressed by Epithelial Cells extracellular matrix in the bleomycin-treated lung, Western blots were performed on RIPA-insoluble fractions of un-To investigate the site of expression of increased basigin mRNA after intratracheal bleomycin, in situ hybridization treated lung and lung 14 d after bleomycin. Positive controls were done using testes. Basigin in testes was almost exclu-was performed. Testis, used as a positive control, showed strong signals ( Figures 4A and 4B) , which is consistent with sively present in the RIPA-soluble fraction and appeared at ‫ق‬ 27 kD and 50 kD; there was little detectable basigin previous data (4) . There was minimal signal detectable in the normal lung ( Figures 4C and 4D) . In contrast, basigin in the RIPA-insoluble fraction (Figure 2, lanes 1 and 2) . In untreated lung, a basigin band was present at ‫ق‬ 27 kD in mRNA was prominent in airway and alveolar epithelium in bleomycin-treated lungs at 7 and 14 d ( Figures 4E, 4F , the RIPA-insoluble fraction of normal lung (Figure 2, lane  3) . In comparison, there was a much stronger signal at 4G, and 4H). Signals for basigin mRNA were not observed in fibrotic areas at 14 d (data not shown), indicating that ‫ق‬ 27 kD in the RIPA-insoluble fraction of bleomycintreated lungs, and there was a prominent band at ‫ق‬ 58 kD fibroblasts and inflammatory cells at the fibro-inflammatory sites are not significant sources of basigin, despite the promi-that was not present in the RIPA-insoluble fraction of untreated lungs (Figure 2, lane 4) . These results support an nent deposition of basigin protein at those sites. association of increased basigin with the fibro-inflammatory Glycosylated Basigin Is Increased in BALF lesions in the bleomycin-treated lung and suggest that at least After Bleomycin some of the basigin associated with the matrix is full length.
Using the monoclonal antibody OX-47, basigin was detect-Lung Basigin mRNA Is Increased After able in BALF from untreated mice and mice lavaged 14 d Intratracheal Bleomycin By quantitative reverse transcriptase-PCR, lung basigin mRNA was present only at low levels in untreated mice (Figure 3 ). However, at 14 d after intratracheal bleomycin instillation, the lung basigin mRNA was significantly in- after intratracheal bleomycin. However, the pattern and at ‫ق‬ 27 kD and faint bands intermediate between the upper amount of signal was different between the two groups. In and lower bands. Thus, post-bleomycin BALF has increased BALF from untreated animals, there was a single band at basigin compared with BALF from untreated lungs, and ‫ق‬ 55 kD ( Figure 5A, lanes 1-3) . In BALF from bleomycinbasigin probably consists of unglycosylated and glycosylated treated animals ( Figure 5A, lanes 4-6) the ‫ق‬ 55-kD band forms. To confirm the presence of glycosylated forms of was present but was much more prominent than in BALF basigin in BALF after intratracheal bleomycin, BALF was from untreated animals. In addition, there was a heavy band exposed to N-glycanase to remove asparagine-linked carbohydrates. By Western blot, it was evident that N-glycanase produced a decreased mass of high-molecular-weight basigin and an increase in unglycosylated basigin at ‫ق‬ 27 kD ( Figure 5B ).
Discussion
Basigin is expressed at low levels in normal adult tissues, but its expression is increased in diverse pathologic processes, including malignant tumors of the skin and breast (23), failing myocardium (24, 25), rheumatoid arthritis synovial membrane (26), hepatitis C virus-associated cirrhotic liver (27), and ventilator-injured lung (28). As is evident from the tissues in which basigin expression is increased, basigin can be expressed by malignant cells, structural cells, and inflammatory cells. In the present study, basigin was promi- The molecular basis for the upregulation of basigin ex-other MMPs, to the basigin on tumor cells may be another property of basigin that promotes its effectiveness in en-pression in bleomycin-induced lung injury and in other settings is not known. Binding of Sp1 and Sp3 to an element hancing tumor cell invasiveness (32) . The terminal airway cells and cells comprising alveolar bronchiolization that we in the promoter of human basigin seems to be critical for the regulation of basigin gene expression in macrophages found to express gelatinase B (MMP-9) after intratracheal bleomycin previously were the cells showing basigin expres-(29). The levels of Sp1 and Sp3, and their activation and binding, are affected by a variety of stimuli; thus, different sion in the present study (18). The mechanisms of basigin induction of MMPs have factors may be involved in different pathologic situations.
The distribution of basigin in the lung after intratracheal been only partially defined. Basigin co-immunoprecipitates and co-localizes with ␣3␤1 and ␣6␤1 integrins and can be bleomycin was notable. By in situ hybridization, basigin mRNA at 7 and 14 d was largely confined to airway epithe-cross-linked to these at the cell surface, suggesting an interaction with integrins (33). Downstream effects seem to in-lial cells, whereas by immunohistochemistry it was prominent at fibro-inflammatory sites where there was minimal volve the MAP kinase p38 (34). We have found that recombinant extracellular domain of murine basigin has the basigin mRNA. The apparent association of basigin with extracellular matrix was confirmed by Western blotting of capacity to induce MMP-1 expression in human lung fibroblasts so that this domain of basigin alone may affect MMP insoluble extracellular matrix. Also, basigin was increased in BALF after bleomycin, with various forms not seen in expression by other cells (unpublished observation).
Because basigin and gelatinase B (MMP-9) expression BALF from untreated lungs. In ventilator-induced lung injury, the levels of 31 kD basigin, presumably nonglycosy-at the mRNA level increase and peak at approximately the same time after bleomycin (i.e., 14 d), it is not obvious that lated basigin, and other forms increased. Taken together, these results indicate that in the injured lung a large fraction basigin is a major factor in the upregulation of gelatinase B. Coincident expression of basigin and gelatinases also of the increased basigin becomes dissociated from airway epithelial cells and macrophages, which are the principal occurred in ventilator-induced lung injury. The increases in lung basigin after bleomycin and ventilator-induced injury cellular sources.
The basis for an association between basigin and fibro-included the low-molecular-weight form (28), which is presumably nonglycoslylated and not active in MMP induction inflammatory foci is not clear. It is possible that fibroblasts or inflammatory cells embedded in the fibrotic areas may (9) . Accordingly, the impact of increased basigin expression on MMP production in these models may be less than ex-bind and internalize basigin. Alternatively, basigin may have an affinity for fibrotic extracellular matrix in bleomy-pected based on basigin mRNA. The role of MMPs in pulmonary fibrosis is not well cin-injured lungs, although basigin did not localize to sites of fibrosis in studies of hepatic fibrosis (27) . Although the understood, although increased MMPs have been demonstrated in human and experimental lung fibrosis. In human validity of bleomycin-induced lung injury as a model of human idiopathic pulmonary fibrosis is questioned (30), pulmonary fibrosis, increased MMP-9 expression involving macrophages and epithelial cells is associated with progres-we have observed strong immunostaining for basigin in hyperplastic epithelium in idiopathic pulmonary fibrosis, sive fibrosis (14, 15). We (18) and others (16) have reported increased MMPs in bleomycin-induced lung injury in mice. so that, with regard to basigin expression, there is some similarity (T. Betsuyaku, Y. Fukuda, and R. M. Senior, However, we did not observe more severe fibrosis in MMP-9deficient mice given bleomycin (18), so that MMP-9 does unpublished observations).
The mechanisms that account for liberating basigin from not seem to have an obvious role in limiting the fibrotic reaction, whereas MMP-7 (matrilysin) deficiency is associ-the cells that produce it so that it is found in BALF and at sites of fibrosis are not known. Previous studies have ated with protection from fibrosis (35). Accordingly, the results with MMP-deficient mice suggest that there is not concluded that basigin can become adherent to cells that do not make the protein, as in the case of peri-tumor fibroblasts a simple link between tissue expression of MMPs and the magnitude of fibrosis post-bleomycin. (23). The present results are consistent with this notion; however, the fibro-inflammatory sites that show basigin are Although the capacity to promote MMP expression has been a focal point of many studies of basigin, basigin may not necessarily adjacent to the epithelial cells that are the source of the basigin, suggesting that under some circum-have functions apart from the regulation of MMPs. Basigin deficiency, produced by gene targeting, is associated with stances basigin undergoes significant translocation.
Basigin stimulates production of many MMPs by fibro-a high level of embryonic lethality before E 8.5 (4) . Analysis of basigin-knockout mice that have survived has revealed blasts in vitro, including interstitial collagenase (MMP-1), stromelysin-1 (MMP-3), MMP-2 (8, 9) , MMP-9 (31), and profound disturbances in reproductive function associated with the blockage of spermatogenesis at the first phase of MT1-MMP (10) , and this property has been the focus of much interest since its discovery in 1982 (6) . Basigin also meiosis (4), defective implantation, and endometrial abnormalities (36) . In addition, there are multiple disturbances induces the expression of MMPs in mesenchymal cells in vivo, and one consequence is to promote tumor cell inva-in the central nervous system (19) and an altered mixed lymphocyte reaction (37) . These surviving animals have siveness. It was shown recently that clones of breast cancer cells transfected with basigin cDNA were more tumorigenic poor growth, and most die before 2 months of age with diffuse infiltration of the lungs with lymphocytes and granu-and invasive than control plasmid-transfected cancer cells In summary, we found that basigin is increased in the 
